Increasing Neonatal HIV Test and Treat to Maximize the Long-Term Impact on Infant Health and Novel Infant Antiretroviral Treatment

Inclusion Criteria: 1. Voluntary and informed consent of the mother for her own study participation (if applicable); 2. Voluntary and informed consent of the legal guardian of the child for participation of the child in the study; 3. Mothers/legal guardians ≥18 years of age; 4. Documented maternal HIV infection; 5. Willingness to consent to HIV testing for the child and herself (or just her child); and 6. Willingness to consent to active tracing including home tracing. Exclusion Criteria: 7. Deficiency in the mother, rendering it difficult, if not impossible, for her or her infant to take part in the study or understand the information provided to her. 8. Having delivered more than 72h (3 days) ago; 9. Prisoners; 10. Women presenting with an emergency requiring immediate medical assistance if not resolved at study inclusion; 11. Stillbirths; 12. Infant requiring emergency care (e.g. immediate or rapid occurring life threatening conditions, resuscitation, prolonged obstetric related intensive care, severe jaundice) or born with severe malformation; 13. If within the discretion of the investigator based on recommendation of the gynaecologist or paediatrician in charge study participation would possibly add not acceptable risk or burden to the mother or infant (e.g. significant congenital malformation, health deficiencies, very low birth weight less than 1500g); or 14. Unlikely to comply with protocol as judged by the principal investigator or his designate